Category: Hematology / Myeloproliferative Neoplasm
Essential Thrombocythemia (ET) is a chronic myeloproliferative neoplasm characterized by sustained proliferation of megakaryocytes in the bone marrow, leading to a persistent elevation of platelet count and an increased risk of thrombosis and hemorrhage.
Approximately 0.6-2.5 cases per 100,000 population per year, according to the MPN Research Foundation.
Discover the latest clinical trials and treatments for Essential Thrombocythemia on JourneyForHealth.
View Full Analysis